Rare diseases
Investigational molecules
Locations
Study on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy
GermanyStudy on the Safety and Tolerability of Spartalizumab for Patients with Advanced Cancer
GermanyStudy of utreloxastat (PTC857) in adults with Amyotrophic Lateral Sclerosis (ALS) to evaluate its effectiveness in slowing disease progression
GermanyStudy of Axitinib and Immune Checkpoint Inhibitors for Patients with Untreated Advanced or Metastatic Kidney Cancer
GermanyStudy of Emrusolmin for Treating Adults with Multiple System Atrophy
GermanyStudy on Adjuvant Therapy with Capecitabine for Stage II Colon and Rectal Cancer Patients with Positive ctDNA After Tumor Removal
GermanyStudy of Durvalumab, Tremelimumab, and Lenvatinib with TACE for Patients with Liver Cancer (Hepatocellular Carcinoma)
GermanyStudy on Reducing Lipoprotein Apheresis with Pelacarsen in Patients with High Lipoprotein(a) and Heart Disease in Germany
GermanyStudy on Tranexamic Acid to Reduce Bleeding and Transfusion Needs in Patients Undergoing Major Abdominal Surgery
GermanyStudy on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma
GermanyStudy on Rilvegostomig and Chemotherapy for Patients with Biliary Tract Cancer After Surgery
GermanyStudy on the Safety and Effects of PTC518 for Patients with Huntington's Disease
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
